We are live on
!
Find out more
OptimizeRx
OPRX
OPRX
128 hedge funds and large institutions have $85.8M invested in OptimizeRx in 2026 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 49 increasing their positions, 28 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
288% more call options, than puts
Call options by funds: $1.32M | Put options by funds: $340K
75% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 28
1.02% more ownership
Funds ownership: 71.59% → 72.61% (+1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 29
1% less funds holding
Funds holding: 129 → 128 (-1)
48% less capital invested
Capital invested by funds: $164M → $85.8M (-$78.1M)
Holders
128
Holders Change
-1
Holders Change %
-0.78%
% of All Funds
1.58%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
29
Increased
49
Reduced
28
Closed
29
Calls
$1.32M
Puts
$340K
Net Calls
+$980K
Net Calls Change
-$477K
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$2.15M |
| 2 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$2.13M |
| 3 |
RA
Royce & Associates
New York
|
+$1.91M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.86M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$1.77M |
